Cancer Incidence for Tottenville, Great Kills & Annadale, Richmond (Staten Island) County, 2015-2019
Source: New York State Cancer Registry
| Site of Cancer | Males and Females | Males | Females | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | |
| All Invasive Malignant Tumors | 1137.2 | 560.3 | 545.4-575.5 | 552.8 | 592.9 | 570.1-616.3 | 584.4 | 542.7 | 522.5-563.5 |
| Oral cavity and pharynx | 24.0 | 11.6 | 9.6-14.0 | 16.6 | 17.1 | 13.5-21.4 | 7.4 | 6.8 | 4.7-9.5 |
| Esophagus | 9.2 | 4.4 | 3.2-5.9 | 8.0 | 8.3 | 5.9-11.5 | 1.2 | 1.1 | 0.4-2.6 |
| Stomach | 18.6 | 9.2 | 7.3-11.3 | 11.0 | 12.0 | 8.9-15.8 | 7.6 | 6.9 | 4.8-9.7 |
| Colorectal | 82.4 | 41.6 | 37.6-45.9 | 45.8 | 50.5 | 43.9-57.7 | 36.6 | 34.1 | 29.2-39.6 |
| Colon excluding rectum | 59.0 | 29.8 | 26.4-33.5 | 31.4 | 34.8 | 29.4-40.9 | 27.6 | 25.7 | 21.5-30.5 |
| Rectum & rectosigmoid | 23.4 | 11.8 | 9.7-14.2 | 14.4 | 15.7 | 12.2-20.0 | 9.0 | 8.4 | 6.0-11.4 |
| Liver / intrahepatic bile duct | 22.8 | 10.9 | 8.9-13.2 | 15.8 | 16.1 | 12.6-20.2 | 7.0 | 6.7 | 4.6-9.4 |
| Pancreas | 31.6 | 15.0 | 12.7-17.7 | 15.6 | 16.5 | 12.9-20.8 | 16.0 | 13.8 | 10.9-17.3 |
| Larynx | 8.0 | 3.9 | 2.8-5.4 | 6.0 | 6.8 | 4.5-9.8 | 2.0 | 1.7 | 0.8-3.4 |
| Lung and bronchus | 139.8 | 68.1 | 63.0-73.5 | 66.0 | 75.1 | 66.9-84.0 | 73.8 | 64.2 | 57.7-71.3 |
| Melanoma of the skin | 36.4 | 18.2 | 15.6-21.1 | 20.6 | 21.6 | 17.5-26.4 | 15.8 | 15.5 | 12.2-19.5 |
| Female breast | 164.0 | 151.6 | 141.0-162.8 | ||||||
| Cervix uteri | 7.6 | 8.2 | 5.7-11.4 | ||||||
| Corpus uterus and NOS | 43.4 | 37.2 | 32.3-42.8 | ||||||
| Ovary | 16.0 | 14.5 | 11.4-18.2 | ||||||
| Prostate | 121.0 | 118.6 | 109.0-128.9 | ||||||
| Testis | 3.8 | 5.4 | 3.2-8.4 | ||||||
| Urinary bladder (incl. in situ) | 66.6 | 32.3 | 28.8-36.1 | 50.4 | 55.4 | 48.5-63.0 | 16.2 | 14.1 | 11.1-17.6 |
| Kidney and renal pelvis | 52.4 | 25.2 | 22.1-28.6 | 34.4 | 35.6 | 30.3-41.7 | 18.0 | 16.3 | 13.0-20.2 |
| Brain and other central nervous system | 14.6 | 7.9 | 6.2-10.1 | 7.4 | 8.8 | 6.1-12.3 | 7.2 | 7.0 | 4.8-9.9 |
| Thyroid | 71.4 | 39.3 | 35.2-43.8 | 20.6 | 23.5 | 19.1-28.7 | 50.8 | 54.4 | 47.6-61.8 |
| Hodgkin lymphoma | 5.2 | 3.3 | 2.1-4.9 | 3.4 | 4.3 | 2.5-7.0 | 1.8 | 2.3 | 1.0-4.4 |
| Non-Hodgkin lymphomas | 53.4 | 26.2 | 23.0-29.6 | 28.2 | 30.2 | 25.2-35.8 | 25.2 | 23.1 | 19.1-27.8 |
| Myeloma | 18.8 | 8.9 | 7.1-10.9 | 10.8 | 11.7 | 8.7-15.4 | 8.0 | 6.7 | 4.7-9.3 |
| Leukemias | 37.2 | 19.2 | 16.5-22.3 | 21.4 | 23.6 | 19.2-28.7 | 15.8 | 16.0 | 12.6-20.2 |
Notes
- Incidence data are provisional, November 2021.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYC neighborhoods were defined in terms of Public Use Microdata Areas (PUMAs). PUMAs approximate NYC Community Districts (CDs).
- For more information about PUMAs, please refer to http://www1.nyc.gov/site/planning/data-maps/nyc-population/geographic-reference.page.
